Pathologic response in er-low early-stage breast cancer treated with neoadjuvant pembrolizumab plus chemotherapy
Year: 2025
Type: conference-paper
Source: Brazilian Journal of Oncology
Authors: Renata Colombo Bonadio, Flávia Cavalcanti Balint, Isadora Martins de Sousa, Ana Carolina Marin Comini, Monique Celeste Tavares, Fernanda Madasi, José Bines, Rafael Dal Ponte Ferreira, Daniela Dornelles Rosa, Candice Lima Santos, Zenaide Silva de Souza, Daniele Assad-Suzuki, Júlio Antônio Pereira de Araújo, Débora de Melo Gagliato, Carlos Henrique dos Anjos, Bruna M. Zucchetti, Anezka Ferrari, Mayana Lopes de Brito, Maria Marcela Fernandes Monteiro, Renata Cangussu, Paulo M. Hoff, Maria del Pilar Estevez-Diz, Laura Testa, Romualdo Barroso-Sousa
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: diamond
OpenAlex ID: W4414864796
FWCI:
Cites:
Cited by:
Related to: